Interleukin-11 for Treatment of Hepatitis C-Associated ITP

Publisher： Karger

E-ISSN： 1421-9662|119|2|126-132

ISSN： 0001-5792

Source： Acta Haematologica, Vol.119, Iss.2, 2008-04, pp. : 126-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overexpression of Tumor-Associated Trypsin Inhibitor (SPINK1/TATI) in Hepatitis C-Associated Hepatocellular Carcinoma: Potential Implications for Viral Hepatocarcinogenesis

By  

Oncology Research and Treatment, Vol. 37, Iss. 12, 2014-11 ,pp. : 732-738

Karger

Access to resources Recommend Favorite

Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 409-416

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic variation in the interleukin‐28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1127-1134

John Wiley & Sons Inc

Access to resources Recommend Favorite

P133: Impact of interleukin 28B genotype on the virological responses in chronic hepatitis C treatment

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 87-88

John Wiley & Sons Inc

Access to resources Recommend Favorite

Naturally occurring, resistance‐associated hepatitis C virus NS5A variants are linked to interleukin‐28B genotype and are sensitive to interferon‐based therapy

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E115-E121

John Wiley & Sons Inc

Access to resources Recommend Favorite